MA45770A - Peptides cycliques en tant qu'antagonistes du récepteur c5 - Google Patents
Peptides cycliques en tant qu'antagonistes du récepteur c5Info
- Publication number
- MA45770A MA45770A MA045770A MA45770A MA45770A MA 45770 A MA45770 A MA 45770A MA 045770 A MA045770 A MA 045770A MA 45770 A MA45770 A MA 45770A MA 45770 A MA45770 A MA 45770A
- Authority
- MA
- Morocco
- Prior art keywords
- receptor antagonists
- cyclic peptides
- peptides
- cyclic
- antagonists
- Prior art date
Links
- 102000001189 Cyclic Peptides Human genes 0.000 title 1
- 108010069514 Cyclic Peptides Proteins 0.000 title 1
- 239000002464 receptor antagonist Substances 0.000 title 1
- 229940044551 receptor antagonist Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662368262P | 2016-07-29 | 2016-07-29 | |
| US201762517215P | 2017-06-09 | 2017-06-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA45770A true MA45770A (fr) | 2019-06-05 |
Family
ID=59416754
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA045770A MA45770A (fr) | 2016-07-29 | 2017-07-17 | Peptides cycliques en tant qu'antagonistes du récepteur c5 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20190270778A1 (fr) |
| EP (1) | EP3491005A1 (fr) |
| JP (1) | JP2019532021A (fr) |
| KR (1) | KR20190032534A (fr) |
| CN (1) | CN109563136A (fr) |
| AU (1) | AU2017304103A1 (fr) |
| BR (1) | BR112019001217A2 (fr) |
| CA (1) | CA3031895A1 (fr) |
| IL (1) | IL264537A (fr) |
| MA (1) | MA45770A (fr) |
| MX (1) | MX2019001153A (fr) |
| SG (1) | SG11201811412XA (fr) |
| WO (1) | WO2018020358A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3824906A1 (fr) | 2016-12-21 | 2021-05-26 | Amgen Inc. | Formulations d'anticorps anti-tnf alpha |
| CN118490807A (zh) * | 2024-05-09 | 2024-08-16 | 无锡市第二人民医院 | 一种补体C5a在制备治疗眼科疾病药物中的应用 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
| KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
| GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
| AUPO755097A0 (en) | 1997-06-25 | 1997-07-17 | University Of Queensland, The | Receptor agonist and antagonist |
| AUPR833401A0 (en) | 2001-10-17 | 2001-11-08 | University Of Queensland, The | G protein-coupled receptor antagonists |
| EP1498422A1 (fr) * | 2003-07-17 | 2005-01-19 | Jerini AG | Antagonistes du Recepteur C5a |
| CN1997384A (zh) * | 2004-03-26 | 2007-07-11 | 普罗米克斯有限公司 | 使用补体C5a受体调节剂治疗神经系统病症 |
| EP1838725A1 (fr) | 2005-01-17 | 2007-10-03 | Jerini AG | Antagonistes du recepteur c5a |
-
2017
- 2017-07-17 MX MX2019001153A patent/MX2019001153A/es unknown
- 2017-07-17 KR KR1020197005513A patent/KR20190032534A/ko not_active Withdrawn
- 2017-07-17 AU AU2017304103A patent/AU2017304103A1/en not_active Abandoned
- 2017-07-17 US US16/319,985 patent/US20190270778A1/en not_active Abandoned
- 2017-07-17 WO PCT/IB2017/054314 patent/WO2018020358A1/fr not_active Ceased
- 2017-07-17 CA CA3031895A patent/CA3031895A1/fr not_active Abandoned
- 2017-07-17 JP JP2019504100A patent/JP2019532021A/ja active Pending
- 2017-07-17 CN CN201780047049.4A patent/CN109563136A/zh active Pending
- 2017-07-17 MA MA045770A patent/MA45770A/fr unknown
- 2017-07-17 BR BR112019001217-6A patent/BR112019001217A2/pt not_active IP Right Cessation
- 2017-07-17 SG SG11201811412XA patent/SG11201811412XA/en unknown
- 2017-07-17 EP EP17745516.9A patent/EP3491005A1/fr not_active Withdrawn
-
2019
- 2019-01-29 IL IL264537A patent/IL264537A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL264537A (en) | 2019-02-28 |
| AU2017304103A1 (en) | 2019-01-17 |
| SG11201811412XA (en) | 2019-02-27 |
| KR20190032534A (ko) | 2019-03-27 |
| CA3031895A1 (fr) | 2018-02-01 |
| WO2018020358A1 (fr) | 2018-02-01 |
| BR112019001217A2 (pt) | 2019-04-30 |
| JP2019532021A (ja) | 2019-11-07 |
| CN109563136A (zh) | 2019-04-02 |
| EP3491005A1 (fr) | 2019-06-05 |
| MX2019001153A (es) | 2019-06-10 |
| US20190270778A1 (en) | 2019-09-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3697759A4 (fr) | Antagonistes du récepteur muscarinique de l'acétylcholine m4 | |
| MA50087A (fr) | Vésicules extracellulaires provenant de prevotella | |
| LT3762380T (lt) | Fenilpirolidinono formilpeptido 2 receptoriaus antagonistai | |
| PL3449940T3 (pl) | Preparat zawierający przeciwciała | |
| LT3143037T (lt) | Alfa4beta7 integrino tioeterio peptidų antagonistaii | |
| PL3283110T3 (pl) | Przeciwciała skierowane przeciwko receptorowi interleukiny 36 (il-36r) | |
| EP3344295A4 (fr) | Récepteurs d'antigène chimère tn anti-sialyle | |
| MA54653A (fr) | Modulateurs du récepteur de cxcr7 pipéridine | |
| MA51232A (fr) | Indane-amines utiles en tant qu'antagonistes de pd-l1 | |
| HUE058759T2 (hu) | Módszerek depresszió kezelésére orexin-2 receptor antagonisták alkalmazásával | |
| EP3651762A4 (fr) | Antagonistes du récepteur muscarinique de l'acétylcholine m4 | |
| EP3481814A4 (fr) | Antagonistes de l'intégrine tetrahydronaphthyridinepentanamide | |
| LT3713928T (lt) | Nauji bradikinino b2 receptoriaus antagonistai | |
| EP3732163A4 (fr) | Antagonistes du récepteur muscarinique de l'acétylcholine m4 | |
| EP3349739A4 (fr) | Diarylthiazepineamines carboxyliques utiles en tant qu'agonistes du récepteur opioïde mu | |
| EP3703680A4 (fr) | Antagonistes du récepteur muscarinique m4 à l'acétylcholine | |
| EP3697781A4 (fr) | Antagonistes du récepteur muscarinique de l'acétylcholine m4 | |
| EP3665175A4 (fr) | Antagonistes du récepteur muscarinique de l'acétylcholine m4 | |
| DK3448879T3 (da) | Claudin-6 peptider | |
| EP3684359C0 (fr) | Antagonistes de trpv2 | |
| EP3350167A4 (fr) | Antagonistes du récepteur des androgènes | |
| DK3334721T3 (da) | Cgrp-receptorantagonister | |
| EP3551657A4 (fr) | Récepteurs de chlorotoxines chimériques | |
| EP3383388A4 (fr) | Utilisation d'arylacylsulfonamides en tant qu'antagonistes de blt1 | |
| DK3380115T3 (da) | Peptider fra piwil 1 |